Kuei-Chun (Mark) Wang

Assistant Professor, School of Biological and Health Systems Engineering

Kuei-Chun (Mark) Wang is an assistant professor in the School of Biological and Health Systems Engineering. The Wang lab utilizes molecular and cellular bioengineering techniques, in combination with biomaterials, to develop nanosized therapeutic and imaging agents for enhancing the treatment and diagnosis of cardiovascular disease.

ASU Search Email

Spring 2024

Hanan Alarnous

Biomedical engineering

Development of Biomimetic Nanoparticles for Smooth Muscle Dysfunction

Developing a characterized biomimetic nano drug presents a promising avenue for effective suppression of dysfunctional smooth muscle cells post-intervention.

Program: MORE

Summer 2024

Alexander Benshoof Egan

Biomedical engineering

Leveraging Hybrid Cell Membrane Cloaking for Minimizing Nanoparticle Phagocytosis

Developing hybrid membrane-coated nanoparticles to reduce phagocytosis might improve targeted delivery for cardiovascular disease treatment.

Program: FURI

Fall 2023

Mark Anthony Orlando

Biomedical engineering

Enhancing Arterial Tissue Digestion Methods for Deeper Insights into Arterial Disease

Isolating vascular cells from adjacent tissue scaffolds will facilitate access to study cellular expressions related to vascular diseases.

Program: FURI

Summer 2023

Mark Anthony Orlando

Biomedical engineering

Enhancing Arterial Tissue Digestion Methods for Deeper Insights into Arterial Disease

Isolating vascular cells from adjacent tissue scaffolds will facilitate access to study cellular expressions related to vascular diseases.

Program: FURI

Spring 2023

Kylie Hartana

Biomedical engineering

Optimization of Monocyte-Mimicking Nanoparticles for Precise Targeting of Endothelial Inflammation

Optimizing nanoparticle formulation can improve its selectivity and effectiveness for targeting inflammation associated with cardiovascular diseases.

Program: FURI

Hanan Alarnous

Biomedical engineering

Optimization of a Targeted MRI Contrast Agent to Enhance Atherosclerosis Imaging

Developing a lesion-targeted MRI contrast agent will improve imaging capabilities for the early detection of atherosclerosis.

Program: FURI

Spring 2022

Michelle M. Mungaray

Biomedical engineering

Development of Biomimetic Nanoparticles for Highly Efficient CRISPR Delivery

Developing a novel cell membrane-enclosed nanocarrier for efficient CRISPR/Cas9 plasmid delivery will facilitate gene editing applications.

Program: MORE

Fall 2021

Chamonix Michaud

Biomedical engineering

Development of CRISPR Interference Constructs to Modulate the Phenotypic Switch of Vascular Smooth Muscle Cells

Developing a CRISPR interference approach to suppress the pathological phenotype of vascular smooth muscle cells will help people with vascular stenosis.

Program: FURI

Summer 2021

Chamonix Michaud

Biomedical engineering

Development of a Genome Editing Tool to Target Modulation Genes In Vascular Smooth Muscle Tissue

Developing a genome engineering approach to fine-tune the transcriptional regulation in vascular smooth muscle cells will help people with vascular stenosis.

Program: FURI

Spring 2021

Michelle M. Mungaray

Biomedical engineering

Development of a Genome Engineering Approach for the Modulation of Vascular Phenotypes

The successful implementation of the CRISPR interference system will allow for the advancement of cardiovascular therapeutics.

Program: FURI

Needs Review

Alexander Benshoof Egan

Biomedical engineering

Leveraging Hybrid Cell Membrane Cloaking for Minimizing Nanoparticle Phagocytosis

Developing hybrid membrane-coated nanoparticles to reduce phagocytosis might improve targeted delivery for cardiovascular disease treatment.

Program: FURI